Zoetis Inc. Share Price

Equities

ZTS

US98978V1035

Pharmaceuticals

Market Closed - Nyse 21:00:02 26/04/2024 BST 5-day change 1st Jan Change
158.4 USD +3.30% Intraday chart for Zoetis Inc. +8.14% -19.73%
Sales 2024 * 9.17B 734B Sales 2025 * 9.81B 785B Capitalization 72.39B 5,795B
Net income 2024 * 2.53B 203B Net income 2025 * 2.78B 222B EV / Sales 2024 * 8.37 x
Net Debt 2024 * 4.31B 345B Net Debt 2025 * 3.8B 304B EV / Sales 2025 * 7.77 x
P/E ratio 2024 *
29 x
P/E ratio 2025 *
26.1 x
Employees 14,100
Yield 2024 *
1.07%
Yield 2025 *
1.22%
Free-Float 91.09%
More Fundamentals * Assessed data
Dynamic Chart
1 day+3.30%
1 week+8.14%
Current month-6.38%
1 month-4.38%
3 months-17.28%
6 months+0.22%
Current year-19.73%
More quotes
1 week
144.80
Extreme 144.8
158.74
1 month
144.80
Extreme 144.8
171.14
Current year
144.80
Extreme 144.8
200.53
1 year
144.80
Extreme 144.8
201.92
3 years
124.15
Extreme 124.1483
249.27
5 years
90.14
Extreme 90.14
249.27
10 years
29.56
Extreme 29.56
249.27
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 31/12/11
Director of Finance/CFO 52 31/05/21
Chief Tech/Sci/R&D Officer - 31/12/10
Members of the board TitleAgeSince
Chairman 71 31/12/12
Director/Board Member 73 31/07/13
Director/Board Member 74 31/05/13
More insiders
Date Price Change Volume
26/04/24 158.4 +3.30% 5,236,463
25/04/24 153.4 +1.64% 4,567,161
24/04/24 150.9 +0.88% 3,640,463
23/04/24 149.6 +2.76% 4,315,288
22/04/24 145.5 -0.66% 4,545,111

Delayed Quote Nyse, April 26, 2024 at 09:00 pm

More quotes
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%); - livestock (34.5%): cattle (51.6% of sales), swine (20.2%), poultry (17.1%), fish (7.6%) and other (3.5%); - other (1.1%). Net sales break down by family of products into parasiticides (23%), vaccines (21.3%), dermatological products (16.4%), anti-infectives (13.4%), medical food additives (4.5%), diagnostic products (4.4%) and other (17%). At the end of 2022, the group has 29 production sites worldwide. The United States accounts for 53.4% of net sales.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
158.4 USD
Average target price
215.2 USD
Spread / Average Target
+35.83%
Consensus